Mohit Malhotra

Employment

• Farcast Biosciences CEO and co-Founder
  2019 - Present

Education

• University of Delhi MBE
  1995 - 1997
• University of Delhi BE, Hons
  1987 - 1991

Projects & Funding

Projects & funding information is unavailable.

Publications (5)

• Leveraging the Stabl framework for anti-PD1 response biomarker discovery in head and neck squamous cell carcinoma using the TruTumor ex vivo platform
  SITC Annual Meeting 2025 2025
  +Save
•  Understanding the role of tumor immune microenvironment in determining response to immune checkpoint inhibitor in colorectal cancer
  SITC Annual Meeting 2025 2025
  +Save
• ILT2 and ILT4 Drive Myeloid Suppression via Both Overlapping and Distinct Mechanisms
  Cancer Immunology Research 2024 DOI: 10.1158/2326-6066.cir-23-0568
  +Save
• Tumor histoculture captures the dynamic interactions between tumor and immune components in response to anti-PD1 in head and neck cancer
  Nature Communications 2024
  +Save
• Identification of tumor microenvironment–informed exosome biomarkers for predicting response to anti-PD1 therapy
  AACR Meeting 2025
  +Save